October 30, 2023
CCS Young Investigator Award to William McIntyre
PHRI Investigator, William McIntyre received the 2023 Canadian Cardiovascular Society (CCS) Young Investigator Award at the annual Canadian Cardiovascular Congress...
Read More
October 24, 2023
Sixth Annual Janice Pogue Lectureship in Biostatistics
In honor of Janice Pogue, the visionary founder of PHRI’s statistical group, PHRI researchers convened for the 6th Annual Janice...
Read More
October 20, 2023
Marie Pigeyre wins 2023 Cardiometabolic Research Award
PHRI Scientist Marie Pigeyre received the 2023 Cardiometabolic Research Award. This esteemed recognition was presented by the Canadian Cardiovascular Society...
Read More
October 20, 2023
Proceed with caution: Anticoagulation in CAA-related ICrH survivors with atrial fibrillation
PHRI Scientist Ashkan Shoamanesh wants physicians treating intracranial hemorrhage (ICrH) survivors with atrial fibrillation (Afib) to proceed with caution when...
Read More
October 12, 2023
PHRI at the World Stroke Congress 2023
Seven of PHRI distinguished Principal Investigators (PIs) have come together with over 3600 fellow stroke experts worldwide for the 15th...
Read More
August 29, 2023
Hertzel Gerstein elected Fellow of the Royal Society of Canada
PHRI Senior Scientist and Deputy Director, Hertzel Gerstein, has been elected as a Fellow in the Royal Society of Canada...
Read More
August 28, 2023
Frailty in patients with heart failure
Physical frailty is a characteristic that should be evaluated to assess the risk of poor outcomes in patients with heart...
Read More
August 26, 2023
Modifiable risk factors responsible for half of CVD globally
More than half of all heart attacks and strokes are avoidable by checking and treating the five most common cardiovascular...
Read More
August 25, 2023
Colchicine did not reduce cardiovascular complications in non-cardiac thoracic surgery, but encouraging signals found
A large, international study in patients undergoing non-cardiac thoracic surgery found that the anti-inflammatory drug, colchicine, did not significantly reduce...
Read More
August 18, 2023
CIHR project grants Spring 2023 winners
More than $6.1 million has been awarded in total to PHRI studies in the Spring 2023 project grant competition of...
Read More
August 14, 2023
Risk factors for oral anticoagulant-associated ICH
In an interview during the European Stroke Organisation Conference (ESOC 2023) in Munich, Germany, PHRI Scientist Ashkan Shoamanesh, in a video...
Read More
August 11, 2023
Health equity symposium
A strong line-up of racialized women working in health equity research during the COVID pandemic will lecture at a new...
Read More
August 10, 2023
PHRI at Joint Statistical Meetings 2023
PHRI participated in the Joint Statistical Meetings (JSM 2023) August 5 – 10 in Toronto – the largest gathering of...
Read More
July 26, 2023
Polypills added to WHO Essential Medicines List
Polypills, aka fixed dose combination (FDC) therapy, have been added for the first time to the 2023 Essential Medicines List...
Read More
July 6, 2023
PURE Healthy Diet truly global, focused on protective foods
In the most diverse study of nutrition and health outcomes in the world – and the only study with sufficient...
Read More